Over the last 7 days, the market has remained flat, but it has risen 12% in the past year, with earnings expected to grow by 18% per annum in the coming years. Investing in penny stocks — a term that may feel outdated yet remains relevant — can still open doors to growth opportunities, typically in smaller or newer companies. We'll spotlight several penny stocks that stand out for their financial strength, making them promising candidates for investors seeking under-the-radar companies poised for long-term success.
Let's review some notable picks from our screened stocks.
Standard BioTools (LAB)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Standard BioTools Inc. develops, manufactures, and sells instrumentation, consumables, and services for scientists and biomedical researchers globally, with a market cap of $292.35 million.
Operations: The company generates revenue from its Medical Products segment, which totaled $84.60 million.
Market Cap: $292.35M
Standard BioTools Inc., with a market cap of US$292.35 million, is currently unprofitable and not expected to achieve profitability in the next three years. Despite having a seasoned management team and sufficient cash runway for over three years, the company faces challenges such as declining revenue, which was US$20.1 million for Q2 2026 compared to US$21.76 million a year ago, and recent delisting warnings from Nasdaq due to share price issues. The company has filed shelf registrations totaling over US$49 million as it navigates potential financial restructuring amidst an impending merger with Treeline Biosciences.
- Click here and access our complete financial health analysis report to understand the dynamics of Standard BioTools.
- Review our growth performance report to gain insights into Standard BioTools' future.
QuantumScape (QS)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: QuantumScape Corporation develops solid-state lithium-metal battery technology for electric vehicles and other applications in the United States, with a market cap of approximately $2.83 billion.
Operations: Currently, there are no reported revenue segments for the company.
Market Cap: $2.83B
QuantumScape Corporation, with a market cap of US$2.83 billion, remains pre-revenue and unprofitable but has managed to reduce its losses over the past five years by 12.4% annually. The company is debt-free and boasts substantial short-term assets of US$869.1 million, comfortably covering both its short and long-term liabilities. Despite not being forecasted to achieve profitability in the next three years, QuantumScape maintains a robust cash runway exceeding three years at current cash flow rates. Recent earnings reports indicate a reduced net loss for Q2 2026 compared to the previous year, highlighting ongoing efforts towards financial improvement.
- Navigate through the intricacies of QuantumScape with our comprehensive balance sheet health report here.
- Learn about QuantumScape's future growth trajectory here.
Amplify Energy (AMPY)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Amplify Energy Corp. is involved in acquiring, developing, exploiting, and producing oil and natural gas properties in the United States with a market cap of $180.75 million.
Operations: The company's revenue is derived from the exploration, development, and production of oil and natural gas, totaling $213.1 million.
Market Cap: $180.75M
Amplify Energy Corp., with a market cap of US$180.75 million, has shown significant earnings growth, increasing by 34.4% over the past year, surpassing industry averages. The company is debt-free and maintains stable weekly volatility at 7%. Despite a notable one-off gain of US$44.3 million impacting recent financial results, Amplify's net profit margins have improved to 9.5%. However, its short-term assets of US$65.7 million do not cover long-term liabilities of US$86.7 million. Recent announcements include a share repurchase program worth up to US$15 million and updated production guidance for the year ending December 2026.
- Dive into the specifics of Amplify Energy here with our thorough balance sheet health report.
- Gain insights into Amplify Energy's outlook and expected performance with our report on the company's earnings estimates.
Key Takeaways
- Reveal the 311 hidden gems among our US Penny Stocks screener with a single click here.
- Searching for a Fresh Perspective? AI is about to change healthcare. These 128 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com